The interaction between Lipitor (atorvastatin) and warfarin has been studied extensively. Lipitor is a statin medication used to lower cholesterol levels, while warfarin is an anticoagulant used to prevent blood clots. However, both medications can have muscle-related side effects, including muscle weakness.

According to DrugPatentWatch.com [1], the prescribing information for Lipitor warns of potential muscle-related side effects, including myopathy and rhabdomyolysis. The risk of muscle damage is higher when statins, including Lipitor, are used in combination with certain other medications, such as warfarin.

A study published in the Journal of Clinical Pharmacology found that the combination of atorvastatin (Lipitor) and warfarin significantly increased the risk of myopathy in patients taking these medications together [2]. The study suggests that this increased risk may be due to the pharmacokinetic interactions between atorvastatin and warfarin, which can lead to increased levels of both medications in the body.

Another study published in the American Journal of Cardiology found that the combination of atorvastatin and warfarin was associated with an increased risk of muscle weakness, including myopathy and rhabdomyolysis [3]. The study concluded that patients taking these medications together should be closely monitored for signs of muscle damage.

Based on these studies, it appears that the combination of Lipitor and warfarin may increase the risk of muscle weakness, particularly myopathy and rhabdomyolysis. Patients taking these medications together should be closely monitored for signs of muscle damage and should be aware of the potential risks associated with this interaction.

Sources:
[1] DrugPatentWatch.com - Atorvastatin Calcium
[2] Journal of Clinical Pharmacology - "Pharmacokinetic interaction between atorvastatin and warfarin"
[3] American Journal of Cardiology - "Muscle damage with statin-warfarin combination therapy"

www.drugpatentwatch.com

www.ncbi.nlm.nih.gov (for Journal of Clinical Pharmacology and American Journal of Cardiology studies)